VCNX - VACCINEX, INC.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 5.7

Open

$ 5.86

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 5.86 - $ 5.86

52 Week Range

$ 4.43 - $ 100.80

Volume

1,264

Average Volume

Market Cap

2.64M

Beta (5Y Monthly)

$ 0.81

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	04-02-2024	12-31-2023	10-K
2	11-13-2023	09-30-2023	10-Q
3	08-14-2023	06-30-2023	10-Q
4	05-15-2023	03-31-2023	10-Q
5	03-31-2023	12-31-2022	10-K
6	11-14-2022	09-30-2022	10-Q
7	08-15-2022	06-30-2022	10-Q
8	05-16-2022	03-31-2022	10-Q
9	03-31-2022	12-31-2021	10-K
10	11-08-2021	09-30-2021	10-Q
11	08-16-2021	06-30-2021	10-Q
12	05-17-2021	03-31-2021	10-Q
13	03-31-2021	12-31-2020	10-K
14	11-13-2020	09-30-2020	10-Q
15	08-14-2020	06-30-2020	10-Q
16	05-14-2020	03-31-2020	10-Q
17	03-09-2020	12-31-2019	10-K
18	11-12-2019	09-30-2019	10-Q
19	08-14-2019	06-30-2019	10-Q
20	05-15-2019	03-31-2019	10-Q
21	03-13-2019	12-31-2018	10-K
22	11-13-2018	09-30-2018	10-Q
23	08-14-2018	06-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 12:06:42

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
04/25/2024 12:06:47

Vaccinex Q4 EPS $(0.33) Up From $(23.10) YoY
04/03/2024 02:59:15

Vaccinex (NASDAQ:VCNX) reported quarterly losses of $(0.33) per share. This is a 98.57 percent increase over losses of $(23.10)...

Vaccinex Expects Topline Data For Phase 1/...
04/02/2024 12:45:47

Vaccinex FY23 EPS $(43.68) Up From $(98.05...
04/02/2024 12:44:53

Vaccinex, Inc. Announces $1.5M Registered ...
03/27/2024 12:31:27

Vaccinex Announces It Has Entered Into Eig...
02/21/2024 13:21:19

Eight new antibody discovery agreements incorporate Vaccinex's powerful ActivMAb® Drug Discovery Platform ActivMab® platfor...

Trading Halt: Halt status updated at 8:55:...
02/20/2024 13:55:04

Trading Halt: Halted at 7:50:00 p.m. ET - ...
02/17/2024 00:50:04

Why Vaccinex (VCNX) Stock Is Trading Lower
02/15/2024 14:31:43

Vaccinex shares are trading lower by 7.1%Thursday morning. The company announced a 1-for-14 reverse stock split.

Vaccinex, Inc. Announces 1-For-14 Reverse ...
02/15/2024 13:06:16

Vaccinex, Inc., (NASDAQ:VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodeg...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
02/14/2024 21:31:06

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
02/09/2024 21:31:09

Why Vaccinex (VCNX) Stock Is Popping Off
02/07/2024 16:09:19

Vaccinex shares are trading higher by 15% during Wednesday's session. The company announced a private placement transaction...

Vaccinex Announces Pricing Of $3.7M Privat...
02/07/2024 13:08:16

accinex, Inc. (NASDAQ:VCNX) ("Vaccinex" or the "Company"), a clinical-stage biotechnology company pioneering a ...

Nasdaq Grants Vaccinex Extension Until Mar...
12/04/2023 13:09:00

Vaccinex Q3 EPS $(1.09) Up From $(1.65) YoY
11/13/2023 13:22:03

Vaccinex (NASDAQ:VCNX) reported quarterly losses of $(1.09) per share. This is a 33.94 percent increase over losses of $(1.65) ...

Vaccinex Reports Clinical Benefit In Inter...
10/31/2023 13:13:05

Vaccinex, Inc. (NASDAQ:VCNX), a clinical-stage biotechnology company, will be reporting novel findings for its lead product, pe...

Vaccinex Reports Effect Of Pepinemab Treat...
10/26/2023 13:31:39

Vaccinex, Inc. (NASDAQ:VCNX), a clinical-stage biotechnology company, today reports novel findings for its lead product, pepine...

On Oct 10, Vaccinex ot Letter From Nasdaq ...
10/13/2023 21:03:08

- SEC Filing